The inhibition of AChE and BChE by taxifolin is likely due to its ability to bind to their active sites, which could have therapeutic implications for the treatment of Alzheimer’s disease and other neurodegenerative disorders. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.